achiote

Condiciones de salud que achiote puede ayudar a apoyar.

• HipocondríaCientífico

  Bixin and norbixin from annatto are potent apocarotenoid antioxidants, with bixin shown to have stronger free-radical scavenging activity than many common carotenoids. A human crossover RCT demonstrated that bixin supplementation (0.05 mg/kg/day for 7 days) reduced LDL susceptibility to copper-induced oxidation ex vivo. Annatto tocotrienols also elevated total antioxidant status by 22% in a clinical study.

• HipotensiónCientífico

  An RCT in 82 metabolic syndrome patients found that delta-tocotrienol from annatto combined with resveratrol reduced systolic blood pressure by 5.2% and diastolic blood pressure by 5.8% over 24 weeks. Animal data show annatto tocotrienols significantly reduce blood pressure in high-fat/high-cholesterol diet-induced hypertensive rodents. Traditional use of annatto as a hypotensive agent is documented in Peruvian herbal medicine.

• Fatiga SuprarrenalCientífico

  A 24-week randomized, double-blind, placebo-controlled trial in 110 type 2 diabetics found that 250 mg/day of annatto-derived delta-tocotrienol significantly reduced fasting blood glucose (6.8%), insulin (7.6%), and HOMA-IR (13.1%). Animal studies also show annatto tocotrienols improve glucose homeostasis and insulin tolerance. The mechanism likely involves reduction of oxidative stress and inflammation that impair insulin signaling.

• Manchas de la edadCientífico

  Annatto-derived tocotrienols have been studied in a human RCT and multiple animal models for their ability to reduce bone resorption and support bone formation. A 12-week placebo-controlled RCT in 89 postmenopausal women with osteopenia showed significant decreases in bone resorption markers and improvements in bone turnover. Animal data consistently show annatto tocotrienol increases osteoblast activity and reduces osteoclast-driven bone loss.

• Válvula IleocecalCientífico

  A clinical trial in 31 hypercholesterolemic adults found that 250 mg/day of annatto delta-tocotrienol reduced total cholesterol by 15% and LDL by 18% within 4 weeks. A 24-week RCT in T2DM patients (n=110) also saw total cholesterol fall 7.2% and LDL fall 8.5%. Annatto tocotrienol inhibits HMG-CoA reductase—the same rate-limiting enzyme targeted by statins.

• ApendicitisCientífico

  Human clinical studies show annatto-derived delta-tocotrienol significantly reduces circulating pro-inflammatory cytokines (TNF-α, IL-6, IL-2, IL-4, IL-8) and CRP. In one RCT, 250 mg/day of annatto tocotrienol reduced CRP and malondialdehyde each by 40% and 34%, respectively. Preclinical data confirm bixin activates Nrf2 and downregulates NLRP3 inflammasome components.

• CulturismoCientífico

  Norbixin from annatto has been studied in animal models of age-related macular degeneration (AMD), showing reduced A2E accumulation in the retina and protection of retinal pigment epithelium cells. In vitro, norbixin outperformed lutein and zeaxanthin in protecting retinal cells from blue-light phototoxicity. A norbixin drug candidate (BIO201) is under development for AMD clinical trials.

• Leche materna (secar)Científico

  A mouse study found annatto tocotrienol supplementation significantly reversed high-fat diet-induced gut microbiome dysbiosis, decreasing Firmicutes (including Ruminococcus lactaris and Lachnospiraceae) and increasing Akkermansia muciniphila, with concurrent improvements in insulin sensitivity and inflammatory markers. This represents the first study linking annatto tocotrienol to gut microbiome modulation.

• JuanetesCientífico

  Annatto-derived delta-tocotrienol has demonstrated cardiovascular benefits in clinical trials including reductions in total cholesterol, LDL, triglycerides, and inflammatory cytokines. A clinical study in hypercholesterolemic subjects found 250 mg/day reduced total cholesterol by 15%, LDL by 18%, and triglycerides by 14% within 4 weeks. Traditional use of annatto seeds as a cardiotonic is documented in indigenous South American medicine.

• Olor de piesCientífico

  Annatto delta-tocotrienol reduced HOMA-IR by 13.1% in a 24-week RCT of 110 T2DM patients. A separate RCT in metabolic syndrome subjects and animal data from Texas Tech University confirm improvements in insulin sensitivity. The proposed mechanism involves reduced oxidative stress and inflammation in insulin-signaling pathways.

• Envenenamiento QuímicoCientífico

  Multiple clinical trials in NAFLD patients show annatto-derived delta-tocotrienol significantly reduces liver enzymes (ALT, AST), fatty liver index, and degree of hepatic steatosis on ultrasound. A 24-week RCT (n=71) using 600 mg/day demonstrated improvements in liver biomarkers, HOMA-IR, and steatosis grade. Animal data also confirm bixin's hepatoprotective effect against toxic insult.

• GingivitisCientífico

  A 24-week RCT in 82 adults with metabolic syndrome found annatto delta-tocotrienol combined with resveratrol improved all five MetS criteria including blood pressure, waist circumference, and triglycerides. A 2025 RCT using tocotrienol-enriched oats (annatto as tocotrienol source) also improved metabolic parameters in MetS patients. Traditional use of annatto for metabolic disorders is documented across Latin American healing systems.

• Infección (bacteriana)Científico

  Annatto-derived tocotrienols have demonstrated anti-osteoporotic effects in one human RCT (89 postmenopausal osteopenic women, 12 weeks) and multiple animal models using postmenopausal and testosterone-deficient rat models. The human trial showed reduced bone resorption biomarkers and improved bone turnover. Long-term bone mineral density studies in humans remain to be conducted.

• QuistesCientífico

  In vitro studies show bixin applied to skin cells prevents UV-induced DNA damage, and dietary tocotrienols accumulate in skin and protect against UVB-induced oxidative stress. Norbixin is under investigation as a photoprotective agent for retinal UV damage. Traditional use of annatto as a sunscreen by Amazonian indigenous peoples is well documented.

• DebilidadCientífico

  Clinical trials consistently show annatto delta-tocotrienol reduces serum triglycerides. In hypercholesterolemic patients, 250 mg/day lowered triglycerides by 14% within 4 weeks. In a 24-week T2DM RCT (n=110), triglycerides fell 10.3%. An RCT in metabolic syndrome (n=82) combining tocotrienol with resveratrol reduced triglycerides by 16%.

• AbrasionesTradicional

  Annatto leaf and bark infusions are documented in traditional Central and South American medicine as remedies for heartburn, stomach upset, and gastrointestinal inflammation. The seeds are described as mildly astringent digestive aids. No human clinical trials have evaluated these claims.

• EccemaTradicional

  Anti-inflammatory preparations of annatto are used in traditional Latin American medicine for joint pain and inflammation. Bixin and tocotrienols from annatto have demonstrated potent inhibition of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) in preclinical and human studies relevant to arthritis pathophysiology. No human clinical trials for arthritis specifically have been conducted.

• EndometriosisTradicional

  Use of annatto leaf preparations as expectorants and for treatment of bronchitis, cough, and pulmonary disorders is documented in Latin American traditional medicine. Leaves and seeds are described as expectorant and cardiotonic in multiple indigenous compendia. No human clinical evidence is available.

• Enfermedad de AlzheimerTradicional

  The application of annatto seed pulp, leaf poultices, or fruit pulp to burns to prevent blistering and scar formation is a well-documented traditional practice across indigenous South American and Caribbean cultures. Bixin's anti-inflammatory carotenoid properties provide plausible mechanistic support, though human clinical trials are absent.

• Trastornos AutoinmunesTradicional

  Antidiarrheal use of annatto seeds (as astringents) and leaf/bark infusions for dysentery and diarrhea is broadly documented in the ethnobotany of Central and South America. Seeds are mildly astringent and have been used for gastrointestinal complaints including diarrhea and dysentery. No human clinical trials exist.

• Sangrado (interno)Tradicional

  Annatto seeds and leaves have been used as antipyretics across multiple indigenous cultures of South America and Southeast Asia. Preparations include boiled leaf poultices applied to the head and body, and decoctions taken orally. No human clinical trials evaluating antipyretic efficacy have been published.

• Costra lácteaTradicional

  Annatto has a long history of topical use in indigenous Amazonian and Mesoamerican cultures for skin care, wound healing, and protection from environmental damage. Its carotenoid and tocotrienol content provide a plausible mechanistic basis for anti-aging effects. Human clinical evidence specific to skin aging or wrinkle reduction from annatto supplementation or topical application is not currently available.

• Enfermedad de CushingTradicional

  Annatto leaf tea and decoctions used as gargles for sore throat and throat infections are documented traditional practices in Latin American and Southeast Asian indigenous medicine. The use is consistent across multiple independent ethnobotanical sources. Human clinical trial evidence is absent.

• Llagas por DentaduraTradicional

  Annatto seeds are documented as having diuretic properties and have been used in Peruvian traditional medicine for cystitis and urinary tract conditions. Leaf decoctions are used for gonorrhea, urinary infections, and prostate disorders. Human clinical evidence is absent.

• DermatitisTradicional

  A decoction of annatto leaves is traditionally used as a vaginal antiseptic douche in Peruvian and Latin American herbal medicine. The use is documented in multiple ethnobotanical sources and attributed to the antimicrobial properties of annatto extracts. Human clinical trial evidence is absent.

• DifteriaTradicional

  Annatto leaf poultices and seed paste applied topically to wounds, cuts, and burns is a thoroughly documented traditional practice across Amazonian, Mesoamerican, and Caribbean indigenous cultures. The antimicrobial and anti-inflammatory properties of bixin provide a plausible mechanism. Controlled human clinical trials for wound healing specifically are not available.

Sistemas corporales que achiote puede ayudar a apoyar.

• No hay sistemas corporales disponibles.